{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:11:34Z","timestamp":1789506694172,"version":"build-2803163510"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation","doi-asserted-by":"publisher","award":["4020745"],"award-info":[{"award-number":["4020745"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008257","name":"Tarbiat Modares University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008257","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015693","name":"Research Institute for Gastroenterology and Liver Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128785","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T03:18:25Z","timestamp":1781147905000},"page":"128785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Design and synthesis of RNA vaccines encoding SAG1 antigen of toxoplasma gondii and evaluation of immunogenicity and its protective efficacy against acute toxoplasmosis in BALB\/c mice"],"prefix":"10.1016","volume":"88","author":[{"given":"Leila","family":"Zaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Ghaffarifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohreh","family":"Sharifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Horton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128785_bb0005","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1017\/S0031182020000451","article-title":"White-tailed deer (Odocoileus virginianus) are a reservoir of a diversity of toxoplasma gondii strains in the USA and pose a risk to consumers of undercooked venison","volume":"147","author":"Dubey","year":"2020","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2026.128785_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.parepi.2024.e00350","article-title":"Global prevalence of Toxoplasma gondii in birds: a systematic review and meta-analysis","author":"Zaki","year":"2024","journal-title":"Parasite Epidemiol Control"},{"key":"10.1016\/j.vaccine.2026.128785_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jogoh.2017.12.003","article-title":"An updated literature review on maternal-Fetal and reproductive disorders of toxoplasma gondii infection","volume":"47","author":"Fallahi","year":"2018","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.vaccine.2026.128785_bb0020","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/s13071-020-04445-z","article-title":"The life-cycle of toxoplasma gondii reviewed using animations","volume":"13","author":"Attias","year":"2020","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.128785_bb0025","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0020-7519(00)00124-7","article-title":"Toxoplasma gondii: from animals to humans","volume":"30","author":"Tenter","year":"2000","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0030","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pt.2022.10.003","article-title":"Is the incidence of congenital toxoplasmosis declining?","volume":"39","author":"Milne","year":"2023","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.894573","article-title":"Congenital toxoplasmosis: the state of the art","volume":"10","author":"Bollani","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/j.vaccine.2026.128785_bb0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1179\/1364859411Y.0000000022","article-title":"Detection of IgM and IgG anti-toxoplasma antibodies in renal transplant recipients using ELFA, ELISA and ISAGA methods: comparison of pre- and post-transplantation status","volume":"105","author":"Gharavi","year":"2011","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1016\/j.vaccine.2026.128785_bb0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005396","article-title":"The diverse role of NK cells in immunity to toxoplasma gondii infection","volume":"12","author":"Gigley","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.vaccine.2026.128785_bb0050","first-page":"514","article-title":"Toxoplasma gondii: preventive and therapeutic effects of morphine and evaluation of treatment parameters of tachyzoites and infected macrophages in vitro and in a murine model","volume":"19","author":"Zaki","year":"2020","journal-title":"EXCLI J"},{"key":"10.1016\/j.vaccine.2026.128785_bb0055","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/CMR.00057-17","article-title":"Treatment of toxoplasmosis: historical perspective, animal models, and current clinical practice","volume":"31","author":"Dunay","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2026.128785_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.fawpar.2019.e00036","article-title":"Treatment of toxoplasmosis: current options and future perspectives","volume":"15","author":"Konstantinovic","year":"2019","journal-title":"Food Waterborne Parasitol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0065","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1080\/21645515.2019.1708669","article-title":"Why vaccines matter: understanding the broader health, economic, and child development benefits of routine vaccination","volume":"16","author":"Nandi","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2026.128785_bb0070","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fmicb.2016.00609","article-title":"Evaluation of Immunoprotection conferred by the subunit vaccines of GRA2 and GRA5 against acute toxoplasmosis in BALB\/cMice","volume":"7","author":"Ching","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0075","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1017\/S003118200000144X","article-title":"A commercial vaccine for ovine toxoplasmosis","volume":"110","author":"Buxton","year":"1995","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2026.128785_bb0080","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pt.2019.01.005","article-title":"Advances in the development of anti-toxoplasma gondii vaccines: challenges, opportunities, and perspectives","volume":"35","author":"Wang","year":"2019","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3390\/vaccines9050413","article-title":"Advances in toxoplasma gondii vaccines: current strategies and challenges for vaccine development","volume":"9","author":"Chu","year":"2021","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128785_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.621997","article-title":"Vaccines in congenital toxoplasmosis: advances and perspectives","volume":"11","author":"Barros","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0095","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.3390\/ijms24032700","article-title":"A comprehensive review of mRNA vaccines","volume":"24","author":"Gote","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2026.128785_bb0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3390\/vaccines7040122","article-title":"Enlisting the mRNA vaccine platform to combat parasitic infections","volume":"7","author":"Versteeg","year":"2019","journal-title":"Vaccines"},{"key":"10.1016\/j.vaccine.2026.128785_bb0105","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","article-title":"mRNA vaccines for infectious diseases: principles, delivery and clinical translation","volume":"20","author":"Chaudhary","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2026.128785_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.coi.2020.01.008","article-title":"Recent advances in mRNA vaccine technology","volume":"65","author":"Pardi","year":"2020","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0115","first-page":"392","article-title":"Expression of plasmid encoded GRA4 gene of toxoplasma gondii RH strain in CHO eukaryotic cells","volume":"13","author":"Aghdasi","year":"2018","journal-title":"Iran J Parasitol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0120","doi-asserted-by":"crossref","DOI":"10.1111\/pim.12419","article-title":"Evaluation of the immune response in BALB\/cmice induced by a novel DNA vaccine expressing GRA 14 against toxoplasma gondii","volume":"39","author":"Ahmadpour","year":"2017","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0125","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2147\/IDR.S209270","article-title":"Assessment of the immunogenicity and protective efficiency of a novel dual-promoter DNA vaccine, harboring SAG1 and GRA7 genes, from RH strain of toxoplasma gondii in BALB\/cmice","volume":"12","author":"Mavi","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.vaccine.2026.128785_bb0130","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/01926230252824761","article-title":"Qualitative and quantitative analysis of nonneoplastic lesions in toxicology studies","volume":"30","author":"Shackelford","year":"2002","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0135","doi-asserted-by":"crossref","first-page":"93","DOI":"10.7774\/cevr.2018.7.2.93","article-title":"Recent Progress in microneme-based vaccines development against toxoplasma gondii","volume":"7","author":"Foroutan","year":"2018","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2026.128785_bb0140","first-page":"259","article-title":"Rhomboid antigens are promising targets in the vaccine development against toxoplasma gondii","volume":"18","author":"Foroutan","year":"2019","journal-title":"EXCLI J"},{"key":"10.1016\/j.vaccine.2026.128785_bb0145","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128785_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2021.105836","article-title":"Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB\/cmice","volume":"216","author":"Khodadadi","year":"2021","journal-title":"Acta Trop"},{"key":"10.1016\/j.vaccine.2026.128785_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.mimet.2019.105696","article-title":"A systematic review on the role of GRA proteins of toxoplasma gondii in host immunization","volume":"165","author":"Rezaei","year":"2019","journal-title":"J Microbiol Methods"},{"key":"10.1016\/j.vaccine.2026.128785_bb0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.7774\/cevr.2019.8.1.4","article-title":"Rhoptry antigens as toxoplasma gondii vaccine target","volume":"8","author":"Foroutan","year":"2019","journal-title":"Clin Exp Vaccine Res"},{"key":"10.1016\/j.vaccine.2026.128785_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2025.107321","article-title":"Immunogenicity of an in-silico designed multi-epitope DNA vaccine encoding ROP21 and ROP29 of toxoplasma gondii against both acute and chronic toxoplasmosis in BALB\/cmice","volume":"200","author":"Karimipour-Saryazdi","year":"2025","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2026.128785_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.rvsc.2023.105054","article-title":"An in house ELISA using recombinant GRA1 and BAG1 proteins as antigen successfully detected toxoplasma gondii infection in a flock of sheep suffering from abortions","volume":"165","author":"Kandemir","year":"2023","journal-title":"Res Vet Sci"},{"key":"10.1016\/j.vaccine.2026.128785_bb0175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.714170","article-title":"Efficacy, immunogenicity and safety of COVID-19 vaccines: a systematic review and meta-analysis","volume":"12","author":"Sharif","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0180","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1038\/s41467-025-61153-x","article-title":"Immune correlates analysis of mRNA-1345 RSV vaccine efficacy clinical trial","volume":"16","author":"Ma","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2026.128785_bb0185","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.pt.2011.03.009","article-title":"Innate responses to toxoplasma gondii in mice and humans","volume":"27","author":"Pifer","year":"2011","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0190","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2018.01936","article-title":"Inhibition of nitric oxide production in activated macrophages caused by Toxoplasma gondii infection occurs by distinct mechanisms in different mouse macrophage cell lines","volume":"9","author":"Cabral","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0195","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40249-025-01332-6","article-title":"A novel combined quadrivalent self-amplifying mRNA-LNP vaccine provokes protective immunity against acute and chronic toxoplasmosis in mice","volume":"14","author":"Wu","year":"2025","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/j.vaccine.2026.128785_bb0200","article-title":"Immunization with a novel mRNA vaccine, TGGT1_216200 mRNA-LNP, prolongs survival time in BALB\/cmice against acute toxoplasmosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0205","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fmicb.2017.00605","article-title":"Induction of protective immunity against toxoplasma gondii in mice by nucleoside triphosphate hydrolase-II (NTPase-II) self-amplifying RNA vaccine encapsulated in lipid nanoparticle (LNP)","volume":"8","author":"Luo","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0210","article-title":"A novel toxoplasma gondii TGGT1_316290 mRNA-LNP vaccine elicits protective immune response against toxoplasmosis in mice","volume":"14","author":"Li","year":"2023","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0215","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fcimb.2020.00387","article-title":"Effect of imiquimod on tachyzoites of toxoplasma gondii and infected macrophages in vitro and in BALB\/cMice","volume":"10","author":"Zaki","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/intimm\/dxae001","article-title":"The role of IFN-\u03b3-mediated host immune responses in monitoring and the elimination of toxoplasma gondii infection","volume":"36","author":"Ihara","year":"2024","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0225","doi-asserted-by":"crossref","DOI":"10.1186\/1756-3305-7-133","article-title":"Phylogeny and virulence divergency analyses of Toxoplasma gondii isolates from China","volume":"7","author":"Li","year":"2014","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2026.128785_bb0230","doi-asserted-by":"crossref","DOI":"10.1177\/03946320221078436","article-title":"Immune response against toxoplasmosis\u2014some recent updates RH: Toxoplasma gondii immune response","volume":"36","author":"Sana","year":"2022","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0235","first-page":"33","article-title":"Role of TNF and IL-1 in infections with toxoplasma gondii","volume":"9","author":"Chang","year":"1990","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2026.128785_bb0240","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/IAI.68.1.407-410.2000","article-title":"Toxoplasma gondii infection induces gene expression and secretion of interleukin 1 (IL-1), IL-6, granulocyte-macrophage colony-stimulating factor, and intercellular adhesion molecule 1 by human retinal pigment epithelial cells","volume":"68","author":"Nagineni","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2026.128785_bb0245","first-page":"762","article-title":"Suppression of RNA recognition by toll-like receptors: the impact of nucleoside modification and the evolution of RNA vaccines","volume":"21","author":"Karik\u00f3","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0250","first-page":"659","article-title":"Cationic lipid mediated delivery systems for nucleic acid therapeutics: mechanisms and safety considerations","volume":"18","author":"Kasten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.vaccine.2026.128785_bb0255","first-page":"512","article-title":"Immunity to vaccines and the role of adjuvants: innate and adaptive responses","volume":"11","author":"Pulendran","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0260","first-page":"178","article-title":"Evaluating the effects of imiquimod on paths of TLRs and inflammatory cytokines signaling in infected macrophages with Leishmania major in vitro and in vivo","volume":"20","author":"Ebrahimisadr","year":"2025","journal-title":"Iran J Parasitol"},{"key":"10.1016\/j.vaccine.2026.128785_bb0265","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-5699(97)01201-2","article-title":"Gene vaccination: plasmid DNA is more than just a blueprint","volume":"19","author":"Tighe","year":"1998","journal-title":"Immunol Today"},{"key":"10.1016\/j.vaccine.2026.128785_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-0556-1-2","article-title":"DNA vaccines: improving expression of antigens","volume":"1","author":"Garmory","year":"2003","journal-title":"Genet Vaccines Ther"},{"key":"10.1016\/j.vaccine.2026.128785_bb0275","first-page":"361","article-title":"Enhancement of antibody immune response to a toxoplasma gondii SAG1-encoded DNA vaccine by formulation with Aluminum phosphate","volume":"7","author":"Solhjoo","year":"2007","journal-title":"J Med Sci (Faisalabad)"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:40:05Z","timestamp":1789504805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":55,"alternative-id":["S0264410X26005943"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128785","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of RNA vaccines encoding SAG1 antigen of toxoplasma gondii and evaluation of immunogenicity and its protective efficacy against acute toxoplasmosis in BALB\/c mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128785","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"128785"}}